![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves New Diabetes Drug Formulation for AstraZenaca
FDA Approves New Diabetes Drug Formulation for AstraZenaca
![Red_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Red_Approved_Stamp.gif?t=1578447203&width=430)
The FDA approved a new formulation of AstraZenaca’s type-2 diabetes treatment Bydureon, the company said.
The approval includes administration by a modified once-weekly, single-dose autoinjector device, the company said.
Bydureon is indicated for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines in addition to diet and exercise.
Upcoming Events
-
21Oct